New Market Study Published: Rectal Cancer - Pipeline Review, H2 2012
Global Markets Direct's, 'Rectal Cancer - Pipeline Review, H2 2012', provides an overview of the Rectal Cancer therapeutic pipeline. This report provides information on the therapeutic development for Rectal Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Rectal Cancer. 'Rectal Cancer - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor...
View full press release